<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02914665</url>
  </required_header>
  <id_info>
    <org_study_id>SPIHF-204</org_study_id>
    <secondary_id>2016-000126-19</secondary_id>
    <nct_id>NCT02914665</nct_id>
  </id_info>
  <brief_title>A Phase 2 Study to Evaluate the Cardiac and Renal Effects of Short Term Treatment With Elamipretide in Patients Hospitalized With Congestion Due to Heart Failure</brief_title>
  <official_title>A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Cardiac and Renal Effects of Short Term Treatment With Elamipretide in Patients Hospitalized With Congestion Due to Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stealth BioTherapeutics Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stealth BioTherapeutics Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a phase 2 randomized, double-blind, placebo-controlled study to evaluate the cardiac
      and renal effects of short term treatment with elamipretide in patients hospitalized with
      congestion due to heart failure
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 20, 2016</start_date>
  <completion_date type="Actual">November 27, 2017</completion_date>
  <primary_completion_date type="Actual">November 27, 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in NT-proBNP between Baseline and Day 8/Early Discharge</measure>
    <time_frame>Baseline to Day 8</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients staying in the same functional renal function class measured with MDRD formula compared to the number of patients with decreasing or increasing renal function measured with MDRD formula</measure>
    <time_frame>Baseline to Day 3 and Day 8</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients showing a decrease in body weight compared to baseline as well as number of patients showing either no decrease or an increase in body weight compared to baseline</measure>
    <time_frame>Baseline to Day 3 and Day 8</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Calculation of decrease or increase in body weight normalised to the average dose (in mg) of furosemide administered</measure>
    <time_frame>Baseline to Day 3 and Day 8</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The patient and physician global assessment is a 7-point scale which either the patient or the physician will assess from 0 to 10 and will be mathematically averaged on a daily basis in order to compare the different averages throughout the study.</measure>
    <time_frame>Baseline to Day 3 and Day 8</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The average daily dose of diuretic (furosemide - adjusted for thiazide dose if administered) between baseline and Day 3 and Day 8/Early Discharge</measure>
    <time_frame>Baseline to Day 3 and Day 8</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All adverse events, serious adverse events and SUSARs will be summarised per treatment group, namely elamipretide versus placebo, and compared at the end of the study.</measure>
    <time_frame>Baseline to Day 8</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Half-life (T1/2)</measure>
    <time_frame>Baseline to Day 8</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area under the concentration - time curve from 0-24 h (AUC 0-24)</measure>
    <time_frame>Baseline to Day 8</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area under the concentration - time curve from 0- infinity (AUC 0-∞)</measure>
    <time_frame>Baseline to Day 8</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peak Plasma Concentration (Cmax)</measure>
    <time_frame>Baseline to Day 8</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>20 mg elamipretide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20 mg elamipretide once daily for 7 consecutive days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo once daily for 7 consecutive days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>elamipretide</intervention_name>
    <description>20 mg elamipretide administered intravenously once daily for 7 consecutive days</description>
    <arm_group_label>20 mg elamipretide</arm_group_label>
    <other_name>MTP-131, Bendavia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo administered intravenously once daily for 7 consecutive days</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A history of chronic heart failure for at least 1 month

          -  Treated with ≥40 mg/day of furosemide or bumetanide ≥1 mg/day or torasemide ≥10 mg/day
             for at least 1 month

          -  In-hospital observation/admission and treatment for ≤72 hours and primary cause for
             admission is heart failure with persistent congestion in the opinion of the
             Investigator (i.e. at least +2 pitting oedema and/or an estimated 8 kg gain in weight
             over baseline over the past 4 weeks) requiring intravenous loop diuretic therapy

          -  Sufficiently severe oedema to justify treatment by an intravenous infusion of
             furosemide of 10 mg/hour for at least 48 hours

          -  Systolic blood pressure &gt;90 mmHg and considered to be haemodynamically stable, in the
             opinion of the Investigator

          -  History of left ventricular ejection fraction (LVEF) ≤40% confirmed in the last 18
             months

          -  NT-proBNP &gt;1500 pg/ml or BNP &gt;500 pg/ml

          -  An eGFR of &gt;30 mL/min/1.73 m2 using the eGFR (mL/min/1.73 m2) = 175 x (Scr)-1.154 x
             (Age)-0.203 x (0.742 if female) x (1.212 if African American)

        Exclusion Criteria:

          -  Acute coronary syndrome, stroke, or transient ischemic attack (TIA), coronary or
             peripheral revascularization procedures, valve procedures, OR any major surgical
             procedure within the previous 6 weeks

          -  Invasive cardiac investigation and/or treatment (i.e. coronary angiography,
             percutaneous coronary intervention [PCI] or surgery) or other surgical procedure
             planned in the next 4 weeks

          -  Use of intravenous radiographic contrast agent within 72 hours prior to screening or
             planned use during the study

          -  Severe, in the investigators opinion, uncorrected valve disease or congenital heart
             disease as the cause for cardiac decompensation

          -  Acute mechanical cause of decompensated heart failure such as papillary muscle rupture

          -  Obstructive or infiltrative cardiomyopathy (e.g. amyloid, sarcoid, etc), suspected
             acute myocarditis, or heart failure related to an untreated metabolic condition (e.g.
             haemochromatosis)

          -  Second or third degree heart block unless the subject has a ventricular pacemaker

          -  Atrial fibrillation/flutter with sustained ventricular response of &gt;130 bpm

          -  Placement of a ventricular resynchronization device within the previous 6 weeks

          -  Treatment or planned treatment with intravenous inotropic agents other than digoxin at
             any time on this admission

          -  Receipt of intravenous vasodilator therapy ≤ 6 hours prior to randomization

          -  The presence of any mechanical assist device or listed for or a history of a heart
             transplant

          -  Severe respiratory disease or anticipated need for mechanical respiratory support
             (i.e. mechanical ventilation)

          -  Anuric in the previous 24 hours

          -  Haemoglobin &lt;9 g/dL at screening or planned blood transfusions in the next 30 days

          -  Serum potassium &gt;5.5 mEq/L

          -  Marked proteinuria suggestive of nephrotic syndrome

          -  Estimated GFR (eGFR) as per MDRD equation &lt;30 ml/min

          -  Serum albumin of &lt; 2.8 g/dL

          -  Liver enzymes (alanine aminotransferase [ALT] and/or aspartate aminotransferase [AST])
             elevation &gt;5 times the upper limit of normal (ULN)

          -  Total bilirubin &gt;2.0 times ULN in the absence of Gilbert's Syndrome

          -  Current or planned ultrafiltration, paracentesis, haemofiltration or dialysis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Onze Lieve Vrouw campus Aalst</name>
      <address>
        <city>Aalst</city>
        <zip>9300</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital ZNA Middelheim</name>
      <address>
        <city>Antwerp</city>
        <zip>2020</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Internal Diseases, &quot;Multiprofile Hospital for Active Treatment Sveta Ekaterina - Dimitrovgrad&quot; EOOD</name>
      <address>
        <city>Dimitrovgrad</city>
        <zip>6400</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinic of Cardiology, &quot;Second Multiprofile Hospital for Active Treatement - Sofia&quot; EAD</name>
      <address>
        <city>Sofia</city>
        <zip>1202</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinic of Cardiology, Multiprofile Hospital for Active Treatment National Heart Hospital&quot; EAD</name>
      <address>
        <city>Sofia</city>
        <zip>1309</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinic of Cardiology, &quot;City Clinic University Multiprofile Hospital for Active Treatment&quot; EOOD</name>
      <address>
        <city>Sofia</city>
        <zip>1407</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinic of Internal Diseases, &quot;Multiprofile Hospital for Active Treatment, &quot;Sveta Anna Sofia&quot; AD</name>
      <address>
        <city>Sofia</city>
        <zip>1750</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Cardiology, &quot;Multiprofile Regional Hospital for Active Treatement Dr. Stefan Cherkezov&quot; AD</name>
      <address>
        <city>Veliko Tarnovo</city>
        <zip>5000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Henri Mondor</name>
      <address>
        <city>Créteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Rangueil</name>
      <address>
        <city>Toulouse Cedex 9</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hungarian Institute Of Cardiology, Department of Adult Cardiology</name>
      <address>
        <city>Budapest</city>
        <zip>1096</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Semmelweis University Heart and Vascular Center</name>
      <address>
        <city>Budapest</city>
        <zip>1122</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>County St. George University Teaching Hospital, Department of Internal Medicine Cardiology</name>
      <address>
        <city>Székesfehérvár</city>
        <zip>8000</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zala County Hospital Cardiology Department</name>
      <address>
        <city>Zalaegerszeg</city>
        <zip>8900</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Daugavpils Regional Hospital</name>
      <address>
        <city>Daugavpils</city>
        <zip>LV5417</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Riga East Clinical University Hospital, Clinic Gailezers</name>
      <address>
        <city>Liepaja</city>
        <zip>LV1038</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Liepaja Regional Hospital</name>
      <address>
        <city>Liepaja</city>
        <zip>LV3402</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pauls Stradins Clinical University Hospital, Latvian Centre of Cardiology</name>
      <address>
        <city>Riga</city>
        <zip>LV1002</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Deventer Hospital</name>
      <address>
        <city>Deventer</city>
        <zip>7416 S</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Gelderse Vallei</name>
      <address>
        <city>Ede</city>
        <zip>6716 RP</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Center Groningen</name>
      <address>
        <city>Groningen</city>
        <zip>9713 GZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Jeroen Bosch</name>
      <address>
        <city>Hertogenbosch</city>
        <zip>5223 GV 's</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Antonius/D&amp;A research Genetic</name>
      <address>
        <city>Sneek</city>
        <zip>8601 ZR</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Elisabeth -Tweesteden</name>
      <address>
        <city>Tilburg</city>
        <zip>5042 AD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospitals Gelre</name>
      <address>
        <city>Zutphen</city>
        <zip>7207 AE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bieganski Provincial Specialist Hospital, Department of Cardiology, Clinic of Cardiology UM</name>
      <address>
        <city>Lodz</city>
        <zip>91-347</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardinal Stefan Wyszynski, Institute of Cardiology, Clinic Heart Failure and Transplantation</name>
      <address>
        <city>Warsaw</city>
        <zip>04-628</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardinal Stefan Wyszynski, Institute of Cardiology, Clinic of Coronary Heart Disease and Structural Heart Disease</name>
      <address>
        <city>Warsaw</city>
        <zip>04-628</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Centre of Serbia, Emergency Centre</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Centre of Serbia, Institute for Cardiovascular Diseases</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Hospital Centre Bezanijska kosa</name>
      <address>
        <city>Belgrade</city>
        <zip>11070</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Hospital Centre Zemun</name>
      <address>
        <city>Belgrade</city>
        <zip>11080</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Centre Nis</name>
      <address>
        <city>Nis</city>
        <zip>18000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute for Cardiovascular Diseases of Vojvodina</name>
      <address>
        <city>Sremska Kamenica</city>
        <zip>21204</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Bellvitge</name>
      <address>
        <city>Barcelona</city>
        <zip>08907</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Complexo Hospitalario Universitario de A Coruña</name>
      <address>
        <city>Coruña</city>
        <zip>15006 A</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario Gregorio Marañón</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Puerta de Hierro Majadahonda</name>
      <address>
        <city>Madrid</city>
        <zip>28222 Majadahonda</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Alvaro Cunqueiro</name>
      <address>
        <city>Pontevedra</city>
        <zip>36312 Vigo</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario de Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46010</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Consorci Hospital General Universitari de Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46014</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari i Politècnic La Fe</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bradford Royal Infirmary</name>
      <address>
        <city>Bradford</city>
        <zip>BD6 6RJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Glenfield Hospital</name>
      <address>
        <city>Leicester</city>
        <zip>LE3 9QP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Torbay Hospital</name>
      <address>
        <city>Torquay</city>
        <zip>TQ2 7AA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Bulgaria</country>
    <country>France</country>
    <country>Hungary</country>
    <country>Latvia</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Serbia</country>
    <country>Spain</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2016</study_first_submitted>
  <study_first_submitted_qc>September 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 26, 2016</study_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Heart failure</keyword>
  <keyword>diuresis</keyword>
  <keyword>dropsy</keyword>
  <keyword>congestion</keyword>
  <keyword>elamipretide</keyword>
  <keyword>MTP-131</keyword>
  <keyword>Bendavia™</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

